Uranium Energy’s Paradox: Production Ramp and $794M Cash Pile Do Little to Halt 34% Monthly Plunge

Uranium Energy Corp advances with NRC docket for conversion facility and new production, but stock drops 47% amid zero revenue, $52M loss, and unhedged cost strategy.

Uranium Energy Corp is living a double life. On one side, the company has just received a key docket number from the U.S. Nuclear Regulatory Commission for its planned conversion facility — a formal step toward becoming the only fully integrated American nuclear fuel supplier. On the other, the stock has lost nearly half its value from January’s high, with a 34% decline in the past 30 days alone. The disconnect between operational milestones and market sentiment has rarely been starker.

The operational story is gathering pace. In Texas, the Burke Hollow in-situ recovery project — the largest new uranium venture of its kind in the U.S. in over a decade — has begun production. Management expects first meaningful volumes in the fourth fiscal quarter. In Wyoming, three new wellfields came online at Christensen Ranch at the end of April, contributing to quarterly output of roughly 32,200 pounds of uranium concentrate. Cumulative production at that site has reached 146,550 pounds. Further drilling campaigns have also been completed: 240 holes at Ludeman and 200 at Sweetwater North, both earmarked as future production centres.

The conversion facility represents the next strategic frontier. UR&C, a UEC subsidiary, now holds an official NRC docket number, clearing the path for a formal license application once engineering work with Fluor Corporation is finished and a site is selected. A shortlist of candidate locations is already in place. This move aligns with Washington’s latest policy push: on April 23, the U.S. Department of Energy launched “Nuclear Dominance 3:33,” an initiative targeting a competitive domestic fuel supply chain, accelerated advanced reactor deployment, and reduced reliance on foreign sources — all by 2033.

Yet the financial picture remains curious. In the third quarter ended April 2026, Uranium Energy reported zero revenue and a net loss of $52.3 million, widening from $30.2 million a year earlier. Over the first nine months of the fiscal year, however, revenue from earlier quarters added $20.2 million to the top line. The balance sheet is rock-solid: $794 million in total liquidity, of which $488 million is pure cash. There is no debt. The company also holds roughly 1.46 million pounds of uranium inventory, valued at $127 million at current market prices, and has kept that stockpile unchanged through the quarter.

Management is sticking to an aggressive unhedged strategy, deliberately avoiding price hedges to ride any uranium rally. But production costs have climbed to $54.61 per pound, which the company blames on regulatory delays and higher state taxes. The rationale is that any near-term cost pressure will be more than offset by rising spot prices, a bet that has not yet paid off in the market’s eyes.

The stock closed at €9.28, marking a 23% drop over the past week and a 47% slide from the January 52-week high of €17.34. Technical indicators look bleak: the share price is well below its 200-day moving average, and the relative strength index is nearing deeply oversold territory. Analyst coverage, however, tells a different story. All six analysts rate the stock a “Strong Buy,” with a consensus price target of $17.83 — nearly double the current level. For now, UEC remains a pure growth bet: strong cash, rising production, but no recurring revenue stream, leaving the stock acutely sensitive to every uranium price wobble. The next major catalyst is likely the site selection decision for the conversion plant.